Atossa's 2013 Revenues Rise 31 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Atossa Genetics said after the close of the market on Thursday that its full-year 2013 revenues grew 31 percent year over year on increased product sales.

The Seattle-based firm recorded $632,558 in total revenues for 2013, up from $481,842 in 2012. While diagnostic testing service revenues slipped to $409,118 from $475,402, product sales rose to $223,440 from $6,440, Atossa said, noting that $205,590 in product sales resulted from the purchase of 10,000 ForeCYTE specimen collection kits by Millennium Healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.